131 related articles for article (PubMed ID: 11334388)
21. Analysis of mutation and expression of c-kit and PDGFR-alpha gene in gastrointestinal stromal tumor.
Zheng S; Chen LR; Wang HJ; Chen SZ
Hepatogastroenterology; 2007 Dec; 54(80):2285-90. PubMed ID: 18265649
[TBL] [Abstract][Full Text] [Related]
22. Gastrointestinal stromal tumors with KIT mutations exhibit a remarkably homogeneous gene expression profile.
Allander SV; Nupponen NN; Ringnér M; Hostetter G; Maher GW; Goldberger N; Chen Y; Carpten J; Elkahloun AG; Meltzer PS
Cancer Res; 2001 Dec; 61(24):8624-8. PubMed ID: 11751374
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic significance of DOG-1 and PKC-θ expression and c-Kit/PDGFRA mutations in gastrointestinal stromal tumours.
Wang C; Jin MS; Zou YB; Gao JN; Li XB; Peng F; Wang HY; Wu ZD; Wang YP; Duan XM
Scand J Gastroenterol; 2013 Sep; 48(9):1055-65. PubMed ID: 23862765
[TBL] [Abstract][Full Text] [Related]
24. Gastrointestinal stromal tumors (GISTs): definition, occurrence, pathology, differential diagnosis and molecular genetics.
Miettinen M; Lasota J
Pol J Pathol; 2003; 54(1):3-24. PubMed ID: 12817876
[TBL] [Abstract][Full Text] [Related]
25. [Gastrointestinal stromal tumors carrying PDGFRalpha mutations occur preferentially in the stomach and exhibit an epithelioid or mixed phenotype].
Wardelmann E; Pauls K; Merkelbach-Bruse S; Hrychyk A; Losen I; Hohenberger P; Büttner R; Pietsch T
Verh Dtsch Ges Pathol; 2004; 88():174-83. PubMed ID: 16892550
[TBL] [Abstract][Full Text] [Related]
26. KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors.
Lux ML; Rubin BP; Biase TL; Chen CJ; Maclure T; Demetri G; Xiao S; Singer S; Fletcher CD; Fletcher JA
Am J Pathol; 2000 Mar; 156(3):791-5. PubMed ID: 10702394
[TBL] [Abstract][Full Text] [Related]
27. High expression of both mutant and wild-type alleles of c-kit in gastrointestinal stromal tumors.
Théou N; Tabone S; Saffroy R; Le Cesne A; Julié C; Cortez A; Lavergne-Slove A; Debuire B; Lemoine A; Emile JF
Biochim Biophys Acta; 2004 Apr; 1688(3):250-6. PubMed ID: 15062876
[TBL] [Abstract][Full Text] [Related]
28. KIT activation is a ubiquitous feature of gastrointestinal stromal tumors.
Rubin BP; Singer S; Tsao C; Duensing A; Lux ML; Ruiz R; Hibbard MK; Chen CJ; Xiao S; Tuveson DA; Demetri GD; Fletcher CD; Fletcher JA
Cancer Res; 2001 Nov; 61(22):8118-21. PubMed ID: 11719439
[TBL] [Abstract][Full Text] [Related]
29. [c-kit and PDGFRA mutations in 60 cases of gastrointestinal stromal tumors (GISTs)].
He HY; Xiang YN; Li Y; Zhong HH; Wu BQ; Zheng J
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 37(3):320-4. PubMed ID: 15968329
[TBL] [Abstract][Full Text] [Related]
30. Spindle cell tumor of urinary bladder serosa with phenotypic and genotypic features of gastrointestinal stromal tumor.
Lasota J; Carlson JA; Miettinen M
Arch Pathol Lab Med; 2000 Jun; 124(6):894-7. PubMed ID: 10835530
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117 (KIT).
Miettinen M; Sobin LH; Sarlomo-Rikala M
Mod Pathol; 2000 Oct; 13(10):1134-42. PubMed ID: 11048809
[TBL] [Abstract][Full Text] [Related]
32. KIT-negative gastrointestinal stromal tumor of the abdominal soft tissue: a clinicopathologic and genetic study of 10 cases.
Yamamoto H; Kojima A; Nagata S; Tomita Y; Takahashi S; Oda Y
Am J Surg Pathol; 2011 Sep; 35(9):1287-95. PubMed ID: 21836495
[TBL] [Abstract][Full Text] [Related]
33. Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors.
Taniguchi M; Nishida T; Hirota S; Isozaki K; Ito T; Nomura T; Matsuda H; Kitamura Y
Cancer Res; 1999 Sep; 59(17):4297-300. PubMed ID: 10485475
[TBL] [Abstract][Full Text] [Related]
34. Familial gastrointestinal stromal tumor with hyperpigmentation: association with a germline mutation of the c-kit gene.
Maeyama H; Hidaka E; Ota H; Minami S; Kajiyama M; Kuraishi A; Mori H; Matsuda Y; Wada S; Sodeyama H; Nakata S; Kawamura N; Hata S; Watanabe M; Iijima Y; Katsuyama T
Gastroenterology; 2001 Jan; 120(1):210-5. PubMed ID: 11208730
[TBL] [Abstract][Full Text] [Related]
35. [At last, an effective therapy for non-differentiated GI sarcomas (gastro intestinal stromal tumor)].
Des Guetz G; De Mestier P; Pierga JY
J Chir (Paris); 2002 Oct; 139(5):268-73. PubMed ID: 12410126
[TBL] [Abstract][Full Text] [Related]
36. [Recent progress in gastrointestinal stromal tumor (GIST)].
Horiuchi H; Matsuya S; Konishi T
Gan To Kagaku Ryoho; 2002 Sep; 29(9):1495-501. PubMed ID: 12355934
[TBL] [Abstract][Full Text] [Related]
37. Expression profiling of GIST: CD133 is associated with KIT exon 11 mutations, gastric location and poor prognosis.
Arne G; Kristiansson E; Nerman O; Kindblom LG; Ahlman H; Nilsson B; Nilsson O
Int J Cancer; 2011 Sep; 129(5):1149-61. PubMed ID: 21064103
[TBL] [Abstract][Full Text] [Related]
38. Telomerase activity as prognostic factor in gastrointestinal stromal tumors of the stomach.
Kawai J; Kodera Y; Fujiwara M; Kasai Y; Nagasaka T; Koike M; Hibi K; Ito K; Akiyama S; Nakao A
Hepatogastroenterology; 2005; 52(63):959-64. PubMed ID: 15966241
[TBL] [Abstract][Full Text] [Related]
39. High incidence of microscopic gastrointestinal stromal tumors in the stomach.
Kawanowa K; Sakuma Y; Sakurai S; Hishima T; Iwasaki Y; Saito K; Hosoya Y; Nakajima T; Funata N
Hum Pathol; 2006 Dec; 37(12):1527-35. PubMed ID: 16996566
[TBL] [Abstract][Full Text] [Related]
40. Spectrum of the KIT Gene Mutations in Gastrointestinal Stromal Tumors in Arab Patients.
Faiyaz-Ul-Haque M; Al-Dayel F; Tulba A; Abalkhail H; Alhussaini H; Memon M; Bazarbashi S; Amin T; Satti MB; Peltekova I; Nawaz Z; Zaidi SH
Asian Pac J Cancer Prev; 2018 Oct; 19(10):2905-2910. PubMed ID: 30362320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
